Reports
Reports
Sale
The global clinical decision support systems market size was valued at USD 1.6 billion in 2022. The major market drivers likely to have an impact globally are growing healthcare infrastructure developments and surging investments in research and development in the medical field. The market is anticipated to grow at a CAGR of 9.8% during the forecast period 2023-2031 to reach a value of USD 3.8 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is holding a significant share in the clinical decision support systems market on account of the growing demand from the medical industry for healthcare information technology solutions. Rapid technological advancements and the surging significance of delivering quality healthcare services are further expected to propel the market growth in the region during the forecast period. A rise in the awareness rate among patients, and surging investments in healthcare IT solutions in North America are likely to boost the market growth.
Meanwhile, the Asia Pacific is expected to witness robust market growth due to the growing investments in the healthcare industry in countries like China, India, Australia, and Japan.
Clinical decision support system (CDSS) is a useful tool in the form of an application that facilitates healthcare providers in offering optimised health care by making informed decisions. The CDSS analyses data, focusing on knowledge management to identify suitable clinical actions that support improved patient care. The CDSS is an adaptation of the DSS or decision support system used in business management applications.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By model, the clinical decision support systems market is divided into:
Based on delivery mode, the market is categorised into:
On the basis of component, the market is segmented into:
By product, the market is segregated into:
On the basis of application, the market is segmented into:
Based on the end-use, the market is categorised into:
The EMR report looks into the regional markets of clinical decision support systems like Latin America, North America, Europe, the Asia Pacific, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The clinical decision support systems market is projected to witness growth during the forecast period on account of the surging adoption of cloud computing coupled with the rising healthcare expenditure. There is also a surging demand for quality care and integrated reliable technical solutions along with the growing adoption of information systems by healthcare institutes and hospitals. These factors, coupled with favourable initiatives by various governments across the globe, are expected to bolster the market growth over the coming years.
Rapid advancements in the fields of bioinformatics and biotechnology are promoting developments and optimisations in data management, storage, and analytics platforms, which is further likely to drive the market growth. Based on the product, the standalone CDSS segment is expected to boost the market owing to its simplicity and low cost.
The report presents a detailed analysis of the following key players in the global clinical decision support systems market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Model |
|
Breakup by Mode of Delivery |
|
Breakup by Component |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Clinical Decision Support Systems Market Overview
3.1 Clinical Decision Support Systems Market Historical Value (2016-2022)
3.2 Clinical Decision Support Systems Market Forecast Value (2023-2031)
4 Clinical Decision Support Systems Market Landscape
4.1 Clinical Decision Support Systems: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Clinical Decision Support Systems Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Clinical Decision Support Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Clinical Decision Support Systems Market Segmentation
6.1 Clinical Decision Support Systems Market by Model
6.1.1 Market Overview
6.1.2 Knowledge-based CDSS
6.1.3 Non Knowledge-based CDSS
6.2 Clinical Decision Support Systems Market by Mode of Delivery
6.2.1 Market Overview
6.2.2 Cloud-based
6.2.3 On-premise
6.3 Clinical Decision Support Systems Market by Component
6.3.1 Market Overview
6.3.2 Hardware
6.3.3 Software
6.3.4 Services
6.4 Clinical Decision Support Systems Market by Application
6.4.1 Market Overview
6.4.2 Medical Diagnosis
6.4.3 Alerts and Reminders
6.4.4 Prescription Decision Support
6.4.5 Information Retrieval
6.4.6 Other Applications
6.5 Clinical Decision Support Systems Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Clinical Decision Support Systems
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Decision Support Systems
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Decision Support Systems
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Decision Support Systems
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Decision Support Systems
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 McKesson Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 IBM Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Siemens Healthineers GmbH
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 NextGen Healthcare Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cerner Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Agfa-Gevaert Group
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Wolters Kluwer N.V.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Koninklijke Philips N.V. (Royal Philips)
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Allscripts Healthcare, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Athenahealth, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Clinical Decision Support Systems - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global clinical decision support systems market reached a value of USD 1.6 billion in 2022.
The market is projected to grow at a CAGR of 9.8% during the forecast period of 2023-2031 to reach a value of USD 3.8 billion by 2031.
The major market drivers likely to have an impact globally are growing healthcare infrastructure developments and surging investments in research and development in the medical field.
The key market trends include increasing geriatric populations worldwide and an increasing penetration of information technology.
The major regions in the market are the Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa.
The various models in the market include Knowledge-based CDSS and Non-knowledge CDSS.
The primary delivery modes systems in the market include on-premise and cloud-based.
The various components include Software, Hardware, and Services.
The various products in the market include Integrated CDSS, Standalone CDSS, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics, among others.
The different applications include clinical drug information, disease and condition management, and clinical informatics and surveillance, among others.
The various end-uses in the market include clinics, and hospitals, ambulatory surgical centres, among others.
The major players in the market are Cerner Corporation, IBM Corporation, Koninklijke Philips N.V., Wolters Kluwer N.V., Zynx Health, Inc., among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.